Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome. [electronic resource]
Producer: 20171116Description: e442 p. digitalISSN:- 2044-5385
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Combined Modality Therapy
- Core Binding Factors -- genetics
- DNA Methylation
- DNA Mutational Analysis
- DNA-Binding Proteins -- genetics
- Dioxygenases
- Female
- Hematopoietic Stem Cell Transplantation -- methods
- High-Throughput Nucleotide Sequencing
- Humans
- Leukemia, Myeloid, Acute -- genetics
- Male
- Middle Aged
- Mutation
- Prognosis
- Proto-Oncogene Proteins -- genetics
- Proto-Oncogene Proteins c-kit -- genetics
- Signal Transduction
- Survival Analysis
- Translocation, Genetic
- Transplantation, Homologous
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.